Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans.
Reyes-González S, de Las Barreras C, Reynaldo G, Rodríguez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Reyes-González S, et al. Among authors: rodriguez vera l. Drug Metab Pers Ther. 2020 Aug 19:/j/dmdi.ahead-of-print/dmdi-2020-0135/dmdi-2020-0135.xml. doi: 10.1515/dmdi-2020-0135. Online ahead of print. Drug Metab Pers Ther. 2020. PMID: 32809952 Free PMC article.
Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans.
Reyes-González S, de Las Barreras C, Reynaldo G, Rodríguez-Vera L, Vlaar C, Mejias VL, Monbaliu JM, Stelzer T, Mangas V, Duconge J. Reyes-González S, et al. Among authors: rodriguez vera l. Drug Metab Pers Ther. 2020 Aug 18;35(4). doi: 10.1515/dmpt-2020-0135. Drug Metab Pers Ther. 2020. PMID: 34704696
New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model.
Rodríguez-Fernández K, Reynaldo-Fernández G, Reyes-González S, de Las Barreras C, Rodríguez-Vera L, Vlaar C, Monbaliu JM, Stelzer T, Duconge J, Mangas-Sanjuan V. Rodríguez-Fernández K, et al. Among authors: rodriguez vera l. Biomed Pharmacother. 2024 Jan;170:115977. doi: 10.1016/j.biopha.2023.115977. Epub 2023 Dec 6. Biomed Pharmacother. 2024. PMID: 38056237 Free PMC article.
Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
Rodríguez-Escudero I, Cedeño JA, Rodríguez-Nazario I, Reynaldo-Fernández G, Rodríguez-Vera L, Morales N, Jiménez-Vélez B, Ruaño G, Duconge J. Rodríguez-Escudero I, et al. Among authors: rodriguez vera l. J Am Coll Clin Pharm. 2020 Sep;3(6):1028-1037. doi: 10.1002/jac5.1250. Epub 2020 May 2. J Am Coll Clin Pharm. 2020. PMID: 32964197 Free PMC article.
Pharmacokinetic Evaluation of Nimotuzumab in Patients With Autosomal Dominant Polycystic Kidney Disease.
de Castro-Suárez N, Rodríguez-Vera L, Villegas C, Dávalos-Iglesias JM, Bacallao-Mendez R, Llerena-Ferrer B, Leyva-de la Torre C, Lorenzo-Luaces P, Troche-Concepción M, Ramos-Suzarte M. de Castro-Suárez N, et al. J Clin Pharmacol. 2019 Jun;59(6):863-871. doi: 10.1002/jcph.1376. Epub 2019 Jan 11. J Clin Pharmacol. 2019. PMID: 30633365 Clinical Trial.
Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease.
Castro-Suárez N, Trame MN, Ramos-Suzarte M, Dávalos JM, Bacallao-Mendez RA, Maceo-Sinabele AR, Mangas-Sanjuán V, Reynaldo-Fernández G, Rodríguez-Vera L. Castro-Suárez N, et al. Among authors: rodriguez vera l. Pharmaceutics. 2020 Nov 26;12(12):1147. doi: 10.3390/pharmaceutics12121147. Pharmaceutics. 2020. PMID: 33256255 Free PMC article.
15 results